SG/PUT/AMGEN/300/0.1/21.03.25 | Market Closed - Boerse Frankfurt Warrants 15:43:33 2024-06-28 EDT | ||
| 2.05 EUR | +0.49% |
|
| Current month | -18.33% | ||
| 1 month | -22.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 2.05 | +0.49% |
| 24-06-27 | 2.04 | +0.99% |
| 24-06-26 | 2.02 | +10.99% |
| 24-06-25 | 1.82 | -5.21% |
| 24-06-24 | 1.92 | -9.86% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 03:43 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SU6QQR |
| ISIN | DE000SU6QQR6 |
| Date issued | 2024-01-08 |
| Strike | 300 $ |
| Maturity | 2025-03-21 (266 Days) |
| Parity | 10 : 1 |
| Emission price | 2.8 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.68 € |
|---|---|
| Lowest since issue | 1.73 € |
| Spread | 0.03 € |
| Spread % | 1.44% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Warrants
- Warrant
